GWS
CERE

Glassman Wealth Services’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Glassman Wealth Services’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13
Closed -$413 – 2078
2023
Q2 		$413 Buy
+13
New +$413 ﹤0.01% 1676